What is the prevalence of Testicular cancer?

Testicular cancer is the most common malignancy in males aged 15 to 35, though it is considered rare compared to other adult cancers, accounting for approximately 1% of all male cancers. While incidence rates vary globally, it is estimated that the lifetime risk for a male to develop testicular cancer is about 1 in 250, with high survival rates due to effective treatment protocols.

What is the current incidence and prevalence of testicular cancer?

According to the American Cancer Society, approximately 9,760 new cases of testicular cancer are diagnosed in the United States annually. Because the condition has a very high cure rate, the prevalence—the number of people currently living with a history of the disease—is significantly higher than the annual incidence. It is important to note that these statistics reflect clinical reports, and true prevalence may be slightly higher due to asymptomatic cases that resolve or go undiagnosed.

How does age and geography affect testicular cancer risk?

Testicular cancer predominantly affects young and middle-aged men, with the average age at diagnosis being 33. While it can occur in infants and older men, these cases are rare. There are notable geographic and ethnic variations in the prevalence of testicular cancer:

• Geographic trends: Rates are highest in Northern Europe, North America, and Australia.


• Ethnic trends: Caucasian men have a significantly higher risk compared to men of African or Asian descent.


• Risk factors: A personal or family history of testicular cancer and conditions like cryptorchidism (undescended testicle) increase individual risk.

Are there challenges in collecting data on testicular cancer?

While testicular cancer is well-documented in cancer registries, challenges remain in global data collection. In some regions, limited access to screening and urological care can lead to underreporting. At DiseaseMaps.org, we have 4 community members sharing their experiences with testicular cancer, providing a valuable, real-world perspective that complements clinical data by highlighting the patient journey beyond the initial diagnosis.

Next steps

• Perform regular self-exams to identify any lumps, swelling, or changes in the testicles.


• Consult a urologist if you notice persistent discomfort or physical changes.


• Connect with the community at DiseaseMaps.org to share experiences with others managing testicular cancer.


• Review resources from the Testicular Cancer Foundation for patient support and clinical trial information.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.

References

• American Cancer Society: Key Statistics for Testicular Cancer.


• National Cancer Institute (NCI) SEER Database: Cancer Stat Facts.


• NIH Genetic and Rare Diseases Information Center (GARD): Testicular Cancer overview.


• Orphanet: Rare cancer registry and clinical data.